Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials
Thermo Fisher Expands Direct-to-Patient Service
Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.Contract Pharma Staff 10.27.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
Moderna Completes Enrollment in Phase III COVID-19 Vax Study
COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.Contract Pharma Staff 10.22.20
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Online Exclusives Kristin Brooks, Contract Pharma 10.20.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Breaking News | Clinical Trials | Collaborations & Alliances
Cytocom and Cleveland Biolabs Merge
Combine their businesses in an all-stock transaction.Contract Pharma Staff 10.20.20
-
Breaking News | Clinical Trials
Mereo Makes Leadership Changes
Appoints CFO and SVP, regulatory affairs.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.Contract Pharma Staff 10.16.20
-
Clinical Trials | Information Technology
The Role of Electronic Monitoring in Maintaining Medication Adherence
Digital solutions offer hope to get patients to take their medications properly.Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech
Will serve as CDMO partner for drug substance manufacturing of BNT162b2.Contract Pharma Staff 10.08.20
-
Breaking News | Clinical Trials | Information Technology | Promotions & Moves
Medable Expands Leadership Team
Aims to drive growth and adoption of decentralized clinical trials.Contract Pharma Staff 09.30.20
-
Breaking News | cGMP Manufacture | Clinical Trials | Drug Development | Drug Discovery | Industry News
BioDuro, Sundia Partner as New CRDMO
Advent International investment creates services company with over 2,000 employees and 10 facilities in China and U.S.Contract Pharma Staff 09.25.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax
Will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose of JNJ-78436735 versus placebo.Contract Pharma Staff 09.23.20
-
Breaking News | Clinical Trials | CRO News | Information Technology
Parexel Acquires Roam Analytics’ NLP Capability
Expands capabilities in Artificial Intelligence and Machine Learning to further streamline and extract insights from unstructured data.Contract Pharma Staff 09.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | CRO News
DoD Selects Pharm-Olam to Support to Operation Warp Speed Vax Trials
To support Phase III clinical trials of one or more lead COVID-19 vaccine candidates being developed under Operation Warp Speed.Contract Pharma Staff 09.23.20
-
Clinical Trials | Drug Development
How to Balance Internal and External Staff Within Outsourcing Models
Strategies to consider in flexed staffing models.John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
ARCA Submits IND for AB201 in COVID-19
AB201, a Phase IIb-ready recombinant protein aims to address the pathologies caused by viral infections from multiple aspects.Contract Pharma Staff 09.21.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development
Boehringer, Mirati Therapeutics Enter Clinical Collaboration
To evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors.Contract Pharma Staff 09.17.20
-
Breaking News | Clinical Trials | Collaborations & Alliances
Vaccinex, Merck Collaborate on Keytruda Combo
Will evaluate pepinemab in combination with Keytruda in HNSCC.Contract Pharma Staff 09.17.20
